<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To determine the frequency and risk factors associated with neonatal chemical <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> in neonates of mothers with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0009800'>gestational diabetes</z:hpo> mellitus (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: A retrospective cohort study of women with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> or <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> and their singleton neonates </plain></SENT>
<SENT sid="2" pm="."><plain>The primary outcome measure was the presence of neonatal chemical <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> (capillary plasma equivalent <z:chebi fb="105" ids="17234">glucose</z:chebi> &lt;45 mg/dl) within 1 h of birth </plain></SENT>
<SENT sid="3" pm="."><plain>Statistical methods included bivariate and multivariate analyses </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: 242 mother infant dyads were identified </plain></SENT>
<SENT sid="5" pm="."><plain>Sixty-eight (28%) were treated with diet, 110 (46%) with <z:chebi fb="0" ids="5441">glyburide</z:chebi>, and 64 (26%) with insulin </plain></SENT>
<SENT sid="6" pm="."><plain>The incidence of neonatal chemical <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> was 18% (44/242) </plain></SENT>
<SENT sid="7" pm="."><plain>The incidence was significantly higher in those requiring pharmacotherapy (25% vs. 3%, p &lt; 0.001) </plain></SENT>
<SENT sid="8" pm="."><plain>The frequency of neonatal chemical <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> between the <z:chebi fb="0" ids="5441">glyburide</z:chebi> and insulin-treated pregnancies did not differ significantly (23% vs. 27%, p = 0.58) </plain></SENT>
<SENT sid="9" pm="."><plain>The frequency of neonatal chemical <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> was statistically associated with birth weight, <z:hpo ids='HP_0001520'>macrosomia</z:hpo> and ponderal index (p &lt; 0.001) </plain></SENT>
<SENT sid="10" pm="."><plain>Neonatal ponderal index was the strongest predictor of <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> (adjusted Odds ratio 5.59) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: Neonatal chemical <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> occurs more frequently in infants from women with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GDM</z:e> treated with <z:chebi fb="0" ids="5441">glyburide</z:chebi> or insulin </plain></SENT>
<SENT sid="12" pm="."><plain>An increased neonatal ponderal index is a strong predictor of significant neonatal chemical <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> </plain></SENT>
</text></document>